<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="141">
  <stage>Registered</stage>
  <submitdate>6/08/2005</submitdate>
  <approvaldate>9/08/2005</approvaldate>
  <actrnumber>ACTRN12605000113651</actrnumber>
  <trial_identification>
    <studytitle>The optimal treatment of obesity: a prospective randomized controlled comparison of best practice medical management versus placement of the Lap-Band System to effect weight loss.</studytitle>
    <scientifictitle>The optimal treatment of obesity: a prospective randomized controlled comparison of best practice medical management versus placement of the Lap-Band System to effect weight loss.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Obesity</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Obese patients will be randomized to either the medical or surgical group. The medical arm will receive treatment with a VLCD plus ongoing individualized care encompassing other obesity drugs as determined and behaviour modification programs. The surgical arm will receive treatment with the Lap-Band System, a laparoscopic adjustable gastric band. Patients will be followed for two years from randomization.</interventions>
    <comparator>best practice medical management</comparator>
    <control>Active</control>
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Weight loss.</outcome>
      <timepoint>At 2 years.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Body composition changes</outcome>
      <timepoint>At 12 and 24 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Comorbidity changes </outcome>
      <timepoint>At 12 and 24 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Functional status changes</outcome>
      <timepoint>At 12 and 24 months measured by SF36, Beck Depression Inventory and Multidimensional Body-Self Relation Questionnaire.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Side effects and economic evaluation.</outcome>
      <timepoint>24 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>BMI 30-35, have identifiable problems either medical, physical or psychosocial with this level of obesity, be able to understand the options, the potential benefits and risks, and be able to comply with the requirements of each program. </inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Lack of acceptance of the randomization process, history of previous abdominal surgery which would potentially preclude the laparoscopic placement of the band, medical issues which contra-indicated either arm of the study including acute myocardial infarction within the past 6 months, dementia, active psychosis, concurrent experimental drug use, autoimmune disease, pregnancy, lactation, illicit drug use, excessive alcohol intake, use of drugs known to affect body composition, cytotoxic drugs, internal malignancy or major organ failure, inability to understand the risks, unrealistic expectation of benefits or likelihood of failure to comply with the follow up requirements of either program.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Intervention recorded and stored in numbered, sealed opaque envelopes organized and maintained by staff member not involved in patient care or scheduling and opened in sequence as randomized.</concealment>
    <sequence>Computer sequence generation.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/11/2000</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>80</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Centre for Obesity Research and Education (CORE)</primarysponsorname>
    <primarysponsoraddress>Commercial Road
Melbourne Vic 3004</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Monash University Department of Surgery</fundingname>
      <fundingaddress>Commercial Road
Melbourne Vic 3004</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Applied Medical</fundingname>
      <fundingaddress>1/32 Windorah St
P.O Box 1545,
Stafford City 4053. Qld.</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Inamed Health</fundingname>
      <fundingaddress>5540 Ekwill Street
Santa Barbara, California, USA 93111</fundingaddress>
      <fundingcountry>United States of America</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Novartis</fundingname>
      <fundingaddress>327 -333 Police Rd
Mulgrave 3170</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>US Surgical</fundingname>
      <fundingaddress>150 Glover Avenue,
Norwalk, Connecticut 06856,
USA</fundingaddress>
      <fundingcountry>United States of America</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>none</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication>Publications

Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. O'Brien PE. Dixon JB. Laurie C. Skinner S. Proietto J. McNeil J. Strauss B. Marks S. Schachter L. Chapman L. Anderson M.  Annals of Internal Medicine. 144(9):625-33, 2006


Dixon JB. Strauss BJ. Laurie C. O'Brien PE. Changes in body composition with weight loss: obese subjects randomized to surgical and medical programs. Obesity. 15(5):1187-98, 2007

Presentations

Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program by Emeritus Professor Paul OBrien at the International Federation for the Surgery of Obesity (IFSO) Europe meeting, Lyon France, April 2006.

Change in body composition with weight loss: Medical and surgical therapies by Associate Professor John Dixon at the 2006 International Federation for the Surgery of Obesity (IFSO)  meeting in Sydney, Australia.
</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Avenue Hospital</ethicname>
      <ethicaddress>The Avenue
Windsor Vic 3181</ethicaddress>
      <ethicapprovaldate />
      <hrec>Trial 027</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Alfred Hospital</ethicname>
      <ethicaddress>Commercial Road
Melbourne Vic 3004</ethicaddress>
      <ethicapprovaldate>6/01/2000</ethicapprovaldate>
      <hrec>166/99</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Monash University SCERH</ethicname>
      <ethicaddress>Building 3D, Clayton Campus
Wellington Road
Clayton</ethicaddress>
      <ethicapprovaldate>11/11/2003</ethicapprovaldate>
      <hrec>2003/458MC</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Professor Paul O'Brien</name>
      <address>Centre for Obesity Research and Education (CORE)
Monash University Medical School
Alfred Hospital
Commercial Road
Melbourne VIC 3004</address>
      <phone>+61 3 99030721</phone>
      <fax>+61 3 95103365</fax>
      <email>paul.obrien@med.monash.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms Cheryl Laurie</name>
      <address>Centre for Obesity Research and Education (CORE)
Monash University Medical School
Alfred Hospital
Commercial Road
Melbourne VIC 3004</address>
      <phone>+61 3 99030721</phone>
      <fax>+61 3 95103365</fax>
      <email>cheryl.laurie@med.monash.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Maureen Dixon</name>
      <address>Centre for Obesity Research and Education (CORE) Monash University Alfred Campus
Commercial Road
Melbourne Vic 3004</address>
      <phone>+61 3 99030686</phone>
      <fax>+61 3 9510 3365</fax>
      <email />
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>